BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23831019)

  • 21. Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21.
    Camporez JP; Asrih M; Zhang D; Kahn M; Samuel VT; Jurczak MJ; Jornayvaz FR
    J Endocrinol; 2015 Sep; 226(3):207-17. PubMed ID: 26203166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGF21 decreases body weight without reducing food intake or bone mineral density in high-fat fed obese rhesus macaque monkeys.
    Andersen B; Straarup EM; Heppner KM; Takahashi DL; Raffaele V; Dissen GA; Lewandowski K; Bödvarsdottir TB; Raun K; Grove KL; Kievit P
    Int J Obes (Lond); 2018 Jun; 42(6):1151-1160. PubMed ID: 29892039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting hypoglycemic effects of PEGylated FGF21 and insulin glargine in mice with type 1 diabetes.
    Xu P; Ye X; Zhang Y; Yuan Q; Liu M; Wu Q; Ren G; Li D
    J Diabetes Complications; 2015; 29(1):5-12. PubMed ID: 25456819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.
    Hata T; Mera Y; Tadaki H; Kuroki Y; Kawai T; Ohta T; Kakutani M
    Diabetes Obes Metab; 2011 May; 13(5):446-54. PubMed ID: 21255216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
    Mustad VA; Demichele S; Huang YS; Mika A; Lubbers N; Berthiaume N; Polakowski J; Zinker B
    Metabolism; 2006 Oct; 55(10):1365-74. PubMed ID: 16979408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.
    Lam TK; van de Werve G; Giacca A
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E281-90. PubMed ID: 12531742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor 21 corrects obesity in mice.
    Coskun T; Bina HA; Schneider MA; Dunbar JD; Hu CC; Chen Y; Moller DE; Kharitonenkov A
    Endocrinology; 2008 Dec; 149(12):6018-27. PubMed ID: 18687777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGF21 decreases food intake and body weight in obese Göttingen minipigs.
    Christoffersen B; Straarup EM; Lykkegaard K; Fels JJ; Sass-Ørum K; Zhang X; Raun K; Andersen B
    Diabetes Obes Metab; 2019 Mar; 21(3):592-600. PubMed ID: 30328263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventive and curative effect of Trigonella foenum-graecum L. seeds in C57BL/6J models of type 2 diabetes induced by high-fat diet.
    Hamza N; Berke B; Cheze C; Le Garrec R; Umar A; Agli AN; Lassalle R; Jové J; Gin H; Moore N
    J Ethnopharmacol; 2012 Jul; 142(2):516-22. PubMed ID: 22633967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired glucose tolerance in rats fed low-carbohydrate, high-fat diets.
    Bielohuby M; Sisley S; Sandoval D; Herbach N; Zengin A; Fischereder M; Menhofer D; Stoehr BJ; Stemmer K; Wanke R; Tschöp MH; Seeley RJ; Bidlingmaier M
    Am J Physiol Endocrinol Metab; 2013 Nov; 305(9):E1059-70. PubMed ID: 23982154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term high-fat diet links the regulation of the insulin-sensitizing fibroblast growth factor-21 and visfatin.
    Sun B; Yang G; Yang M; Liu H; Boden G; Li L
    Cytokine; 2012 Jul; 59(1):131-7. PubMed ID: 22542568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ingestion of eicosapentaenoic acid in the early stage of social isolation reduces a fibroblast growth factor 21 resistant state independently of body weight in KKA(y) mice.
    Nonogaki K; Yamazaki T; Murakami M; Kaji T
    Biochem Biophys Res Commun; 2015 Aug; 464(2):674-7. PubMed ID: 26187667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGF21 Normalizes Plasma Glucose in Mouse Models of Type 1 Diabetes and Insulin Receptor Dysfunction.
    Diener JL; Mowbray S; Huang WJ; Yowe D; Xu J; Caplan S; Misra A; Kapur A; Shapiro J; Ke X; Wu X; Bose A; Panza D; Chen M; Beaulieu V; Gao J
    Endocrinology; 2021 Sep; 162(9):. PubMed ID: 33951176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
    Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
    Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys.
    Véniant MM; Komorowski R; Chen P; Stanislaus S; Winters K; Hager T; Zhou L; Wada R; Hecht R; Xu J
    Endocrinology; 2012 Sep; 153(9):4192-203. PubMed ID: 22798348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-fat diet intake accelerates aging, increases expression of Hsd11b1, and promotes lipid accumulation in liver of SAMP10 mouse.
    Honma T; Shinohara N; Ito J; Kijima R; Sugawara S; Arai T; Tsuduki T; Ikeda I
    Biogerontology; 2012 Apr; 13(2):93-103. PubMed ID: 22033707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver.
    Hsieh PS; Jin JS; Chiang CF; Chan PC; Chen CH; Shih KC
    Obesity (Silver Spring); 2009 Jun; 17(6):1150-7. PubMed ID: 19247274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological characterization of a small molecule inhibitor of c-Jun kinase.
    Cho H; Black SC; Looper D; Shi M; Kelly-Sullivan D; Timofeevski S; Siegel K; Yu XH; McDonnell SR; Chen P; Yie J; Ogilvie KM; Fraser J; Briscoe CP
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1142-51. PubMed ID: 18728225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway.
    Yu D; Ye X; Wu Q; Li S; Yang Y; He J; Liu Y; Zhang X; Yuan Q; Liu M; Li D; Ren G
    Endocrine; 2016 Jun; 52(3):527-40. PubMed ID: 26607153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of excess dietary iron and fat on glucose and lipid metabolism.
    Choi JS; Koh IU; Lee HJ; Kim WH; Song J
    J Nutr Biochem; 2013 Sep; 24(9):1634-44. PubMed ID: 23643521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.